Patents by Inventor Barbara Przewlocka

Barbara Przewlocka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11041010
    Abstract: The invention pertains to novel hybrid peptidomimetics, pharmaceutical composition comprising thereof and use thereof in the treatment of neuropathic pain. The hybrid peptidomimetics according to the invention are comprised of two components: an opioid receptor agonist (OP) and a MC4 receptor antagonist, connected by a linker. The compounds of such a structure will allow to activate opioid receptors with simultaneous blocking of melanocortin type 4 receptors (MC4), which results in enhancing efficiency of the opioid therapy in neuropathic pain.
    Type: Grant
    Filed: July 3, 2018
    Date of Patent: June 22, 2021
    Assignees: Uniwersytet Warszawski, Instytut Farmakologii Polskiej Akademii Nauk
    Inventors: Aleksandra Misicka-Kesik, Ewa Witkowska, Beata Wilenska, Barbara Przewlocka, Joanna Mika, Joanna Starnowska-Sokol, Anna Piotrowska-Murzyn
  • Publication number: 20200207827
    Abstract: The invention pertains to novel hybrid peptidomimetics, pharmaceutical composition comprising thereof and use thereof in the treatment of neuropathic pain. The hybrid peptidomimetics according to the invention are comprised of two components: an opioid receptor agonist (OP) and a MC4 receptor antagonist, connected by a linker. The compounds of such a structure will allow to activate opioid receptors with simultaneous blocking of melanocortin type 4 receptors (MC4), which results in enhancing efficiency of the opioid therapy in neuropathic pain.
    Type: Application
    Filed: July 3, 2018
    Publication date: July 2, 2020
    Inventors: Aleksandra Misicka-Kesik, Ewa Witkowska, Beata Wilenska, Barbara Przewlocka, Joanna Mika, Joanna Starnowska-Sokol, Anna Piotrowska-Murzyn